glp 1 drugs and hashimoto's The Thyroid Twist: How GLP-1 Agonists Are Influencing Autoimmune Thyroid Care Does Using GLP-1 Drugs, Like

They promote a shift from pro-inflammatory M1 macrophages to anti-inflammatory M2 macrophages, thereby creating a reparative hepatic environment (25)

Peptides 77:3846

Ozempic/Wegovy are weekly injections

139 Although generally well tolerated, meta-analysis of 14 clinical trials suggests that long-acting GLP-1RAs (eg, semaglutide, tirzepatide) are associated with lower rates of gastrointestinal side-effects, particularly nausea and vomiting, compared to short-acting agents (Table 2)

The phase II obesity study of retatrutide also included a MASH substudy to assess its effects on the amount of liver fat

Similar content being viewed by others Introduction Amid the continuously increasing global incidence of diabetes, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as a cornerstone in type 2 diabetes treatment, demonstrating remarkable efficacy in glycemic control and cardiovascular risk reduction [1, 2]